Press release
Hereditary Angioedema Market is Expecting Worldwide Growth by 2017 – 2025
flow of blood or lymphatic fluid, continuous accumulation of fluids outside of the blood vessels, results in swelling of tissues in the arms, feet, intestinal tract, face, or airway. Stress or Minor trauma may also trigger an attack, Swelling in the airway can limit breathing and prompt to life-debilitating obstruction of the airway. Around 33% of individuals with this condition faces non-itchy rash called erythema marginatum at the time of an attack. risk of passing the abnormal gene to offspring from affected parent is half (50%) for every pregnancy regardless of the sex of the subsequent child.Hereditary angioedema (HAE) is inherited as an autosomal dominant trait, because of a malfunction or lack of C1 esterase inhibitor. Hereditary angioedema (HAE) classified into three types: gene While Type III HAE is due to the mutation in F12 gene. According to NIH Organization, Hereditary angioedema is evaluated to affect 1 in 50,000 individuals. Type I is major, representing 85% of cases followed by Type II which occurs in 15% of cases, and Type III is extremely rare. This is expected to reflect positive growth in the global Hereditary Angioedema market.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/14452
Hereditary Angioedema Market: Drivers and Restraints
The Hereditary Angioedema Association has assumed a pivotal part in conveying new therapies to the market. They have additionally attempted to increase awareness about products and support services that HAE patients require, this is relied upon to reflect positive development in Hereditary Angioedema market. Increase in a population with the change in lifestyle, Improvement in reimbursement infrastructures and Increase in efforts of pharmaceutical manufacturers and biotechnology companies to come up with new solutions and products to the market which expected to fuel the market revenue for Hereditary Angioedema over the forecast period. However, high expenses of medicines, misdiagnosis of the disorder are few of the factors that can restrain the growth of the Hereditary Angioedema market during the forecast period.
Hereditary Angioedema Market: Segmentation
The global market for Hereditary Angioedema is segmented on the basis of typesngioedema, type of drugs used for the treatment, end user and geography:
based on the type, the Hereditary Angioedema market is segmented into the following:
Type I HAE
Type II HAE
Type III HAE
based on the type of drugs used for the treatment, the Hereditary Angioedema market is segmented into the following:
C1-inhibitors (administered through IV infusion)
Ecallantide (administered through subcutaneous injection)
Icatibant (administered through subcutaneous injection)
based on the end user, the Hereditary Angioedema market is segmented into the following:
Hospitals
clinics
Research centers
Hereditary Angioedema Market: Overview
Hereditary Angioedema may be acquired or inherited; it is predominant in children. Major players in this segment are taking an advanced approach to constructing prevalent products as well as to expand their potential revenues which will lead to increase in the global Hereditary Angioedema market through 2025. Shire plc Recognizes HAE Day(16 May) with Launch of Interactive Website Calling for Inspirational Wishes intends to raise awareness among the overall population, show support and ensure better care with a more accurate diagnosis for those who are challenged with this condition. The increase in awareness, improved management, and better outcomes are the factors that drive the Hereditary Angioedema market that is expected to have a meteoric growth over a forecast period.
Hereditary Angioedema Market: Region-wise Outlook
A geographic condition regarding for Hereditary Angioedema market, it has been segmented into five broad regions: North America, Latin America, Europe, Asia-Pacific excluding Japan, and the Middle East & Africa. Majorly North America and Europe dominates the global Hereditary Angioedema market followed by Asia- Pacific. Chang in lifestyle and continuous efforts in the management of healthcare services demonstrates the elevation of the Hereditary Angioedema market.
Hereditary Angioedema Market: Key Market Participants
Major market players of hereditary angioedema market constitute: BioCryst Pharmaceuticals, Inc, CSL Limited, Pharming Group NV, Salix Pharmaceuticals, Shire plc.
To view complete report @ http://www.persistencemarketresearch.com/market-research/hereditary-angioedema-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Market is Expecting Worldwide Growth by 2017 – 2025 here
News-ID: 654611 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Hereditary
Hereditary Angioedema Market: An In-Depth Analysis
In 2024, the market for Hereditary Angioedema Market was valued at USD 3.1 billion. It is anticipated to grow to USD 5.9 billion by 2033, with a CAGR of 6.82% over the period 2026-2033.
Hereditary Angioedema Market Overview
The global hereditary angioedema therapeutics market is experiencing significant expansion, driven by increasing awareness, improved diagnostic capabilities, and the introduction of novel treatment options. Advances in genetic research have enabled early and accurate…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…